1 OPTN Update Brian Shepard Chief Executive Officer UNOS November 17, 2015.

Slides:



Advertisements
Similar presentations
OPTN Modifications to Heart Allocation Policy Implemented July 12, 2006 Changed the allocation order for medically urgent (Status 1A and 1B) patients Policy.
Advertisements

Ken Andreoni, MD Chair UNOS Kidney Comm The Ohio State University
Kidney Transplantation Committee Update John J. Friedewald, MD Committee Chair Meetings.
Patricia A. Sheiner, M.D. President, New York Center for Liver Transplantation Director, Liver Transplantation, Westchester Medical Center 1.
The Impact of the Kidney Allocation System Marlene Abe, Transplant Coordinator UCI Medical Center – Orange, California Jim Trisch, Manager – Clinical Services.
Liver and Intestinal Organ Transplantation Committee Spring 2014 Update.
UNOS Update.  Updating 2012 Strategic plan  Planning for OPTN and UNOS Strategic Planning RegionsBoard Executive Committee /CAC Community.
Ad Hoc Disease Transmission Advisory Committee Spring 2015.
Proposal to Modify Existing or Establish New Requirements for the Informed Consent of Living Donors (Resolution 18) Living Donor Committee Mary Amanda.
OPTN Living Donor Committee Non Action Items Connie Davis, MD June 26, 2012.
Early Outcomes of Transplant Recipients in the OPTN Kidney Paired Donation Pilot Program Mark Aeder, MD, University Hospitals Case Med Center Darren Stewart,
` Division of Transplantation/OSP/HRSA Allocation of Pancreata for Whole Organ and Islet Transplantation James Burdick, M.D. Director Health Resources.
The Impact of the new Kidney Allocation System on Donation and Transplantation in Region 5.
Kidney Transplantation Committee Spring  Implemented Dec. 4, 2014  6 month data will be shared at Aug-Oct regional meetings  Monitoring community.
November 12, 2014 St. Louis, Missouri OPTN Strategic Planning Feedback Board of Directors.
Simultaneous Liver Kidney (SLK) Allocation Policy Kidney Transplantation Committee Fall
The New Kidney Allocation System Gautham Mogilishetty, MD Associate Professor of Medicine Division of Nephrology and Transplantation University of Cincinnati.
Greater Consistency in Candidate and Deceased Donor HLA Typing Requirements Across Organ Types Histocompatibility Committee Spring 2014.
1 Region 10 Meeting Tim Taber, MD Regional Councillor.
Pediatric Training and Experience Requirements in the Bylaws OPTN/UNOS Board of Directors Eileen Brewer, MD, Chair William Mahle, MD, Vice Chair November.
Liver and Intestinal Organ Transplantation Committee Update Report David Mulligan, MD, Chair OPTN/UNOS Board of Directors Meeting November 12-13, 2014.
Region 4 Meeting Kenneth Washburn, MD Regional Councillor.
Expanding HLA Typing Requirements (Resolution 10) Histocompatibility Committee Dolly Tyan, PhD Chair.
1 Revising Kidney Paired Donation Pilot Program Priority Points Kidney Transplantation Committee Fall 2015.
1 Proposal to Revise Facilitated Pancreas Allocation Policy Pancreas Transplantation Committee Fall 2015.
1 Proposal to Update the HLA Equivalency Tables Histocompatibility Committee Fall 2015.
1 UNOS Update Stuart Sweet, MD Vice-President, OPTN/UNOS Board of Directors Region 10 September 10, 2015.
1 Region 7 Meeting Julie Heimbach, MD Regional Councillor.
Introduction Organ Transplantation Program Update Advisory Committee on Organ Transplantation November 17, 2015 Melissa Greenwald, MD Acting Director Division.
OPTN Minority Affairs Committee Update March 13, 2012 Meeting Chicago O’Hare Hilton.
Redesigning Liver Distribution David Mulligan, MD, Chair Liver & Intestinal Organ Transplantation Committee November 12-13, 2014.
Clarify Policy Language and Process for Individual Waiting Time Transfer Patient Affairs Committee Spring 2015.
1 Kidney Transplantation Committee Spring Recent Public Comment Proposals  OPTN Kidney Paired Donation (KPD) Priority Points  Changes apply.
Improving the OPTN Policy Development Process Executive Committee Fall 2014.
1 Simultaneous Liver-Kidney (SLK) Allocation Kidney Transplantation Committee Spring 2016.
United States Organ Transplantation SRTR & OPTN Annual Data Report, 2011 Kidney.
Guidance for VCA Deceased Donor Authorization (Resolution 7)
Enhancing Liver Distribution
Pediatric Transplantation Committee
Living Donor Transplants
Pediatric Transplantation Committee
Vascularized Composite Allograft (VCA) Transplantation Committee
Kidney Committee Fall 2016.
Lloyd E. Ratner, MD, MPH Regional Councillor
Vascularized Composite Allograft (VCA) Transplantation Committee
Pediatric Transplantation Committee
OPTN/UNOS Kidney Transplantation Committee
OPTN/UNOS Kidney Transplantation Committee
Pediatric Transplantation Committee
Ad Hoc Geography Committee Update
OPTN/UNOS Thoracic Organ Transplantation Committee
Vascularized Composite Allograft (VCA) Transplantation Committee
Pancreas Program Functional Inactivity
Thoracic Organ Transplantation Committee Spring 2019
Removal of DSA and Region from Kidney and Pancreas Distribution
Liver and Intestinal Transplantation Committee
Ethical Implications of Multi-Organ Transplants (MOT)
Pediatric Transplantation Committee
Pediatric Transplantation Committee
Vascularized Composite Allograft (VCA) Transplantation Committee
Liver and Intestinal Organ Transplantation Committee
Liver and Intestinal Organ Transplantation Committee
Liver and Intestinal Organ Transplantation Committee
Vascularized Composite Allograft (VCA) Transplantation Committee
Pancreas Transplantation Committee
Kidney and Kidney/Pancreas Transplantation in a Year
Vascularized Composite Allograft Transplantation Committee Fall 2014
White Paper: Split Versus Whole Liver Transplantation
MPSC Transplant Program Performance Measures (Outcome Measures)
Vascularized Composite Allograft (VCA) Transplantation Committee
Presentation transcript:

1 OPTN Update Brian Shepard Chief Executive Officer UNOS November 17, 2015

2 Strategic Alignment

v Goals

4 Feedback from Regional Surveys

5 Re-Balancing Resource Allocation allocation of effort: Increase transplants 40% Provide equity30% Improve outcomes 15% Promote safety10% Promote efficiency5%

2014 Committee Projects

Committee Project Portfolio

The New Kidney Allocation System (KAS): The First Six Months

Background  KAS implemented Dec 4, 2014  Key goals:  Make better use of available kidneys  Increase transplant opportunities for difficult-to-match patients (increased equity)  Increase fairness by awarding waiting time points based on dialysis start date  Have minimal impact on most candidates KAS: The First Six Months

Background (cont.)  Performance tracked monthly through June (“out of the gate” reports)  Comprehensive, 6-month analysis requested by the kidney committee  Pre-KAS period: June 1, 2013 – December 3, 2014 (18 months)  Post-KAS period: December 4, 2014 – May 31, 2015 (6 months) ( KAS: The First Six Months

Solitary deceased donor transplants under KAS Pre vs. post-KAS trends Over time (per 30 days) KAS implementation On average (Total N=16,406)(Total N=5,388)  Transplant volume has increased slightly (about 1%) post-KAS. KAS: The First Six Months Table II.1a

Who’s getting transplanted under KAS? (1/1) Percentage of Deceased Donor Kidney Transplants by Recipient Age KAS: The First Six Months  More young adults (18-49) are receiving kidney transplants.  Still, over half of transplants are going to age 50+ recipients under KAS. Eras - Pre: 18 months (June 1, 2013 – Dec 3, 2014) Post: 6 months (Dec 4, 2014 – May 31, 2015) Table 1.2a Table II.1b

Who’s getting transplanted under KAS? (2/2) Percentage of Deceased Donor Kidney Transplants by Recipient CPRA  Transplants have increased sharply for CPRA % patients.  Transplants have declined for CPRA=0% and 80-94% patients. KAS: The First Six Months Table 1.2a Table II.1b

CPRA % recipient “bolus effect” KAS implementation  Transplants to CPRA % patients rose sharply after KAS but have been tapering over time, likely due to a bolus effect. KAS: The First Six Months Table A.1d

Who’s getting transplanted under KAS? (3/4) Percentage of Deceased Donor Kidney Transplants by Recipient Duration on Dialysis  More transplants are going to long dialysis duration recipients.  Fewer preemptive (before dialysis) transplants. KAS: The First Six Months Table 1.2a Table II.1b

Who’s getting transplanted under KAS? (4/4) Percentage of Deceased Donor Kidney Transplants by Recipient Race/ethnicity  More African Americans are receiving kidney transplants under KAS.  Transplants have also increased for Hispanics, but declined for Whites. KAS: The First Six Months Table 1.2a Table II.1b

Longevity-matching under KAS Percentage of Deceased Donor Kidney Transplants by KDPI and Recipient Age  Transplants with KDPI 0-20% and recipient age 18-34:  Pre-KAS: 2.5% of transplants / Post-KAS: 6.7% of transplants  Transplants with KDPI 0-20% and recipient age 50+:  Pre-KAS: 10% of transplants / Post-KAS: 4% of transplants KAS: The First Six Months Table II.3b

Geographic distribution of kidney transplants 21.2% 32.3%  More kidneys are being distributed outside recovery OPO’s DSA. KAS: The First Six Months Table II.1b

Geographic distribution of kidney transplants (cont)  No significant changes by OPTN region. KAS: The First Six Months Table II.6

Cold ischemic times for transplanted kidneys  Average CIT increased 6% from 17.0 to 18.1 hours  CIT> 24 hours - Pre-KAS: 18.3%, Post-KAS: 22.9% KAS: The First Six Months Table II.1d (known CIT only)

Delayed graft function (DGF) rates  The percentage of recipients requiring dialysis within the first week after transplant increased from 24.5% pre-KAS to 30.8% after KAS. KAS: The First Six Months Table II.16

Kidney recovery & utilization under KAS Percentage of Recovered Deceased Kidney Donors by KDPI  Total kidney donors recovered per month increased 4% (636 to 661).  However, the distribution by KDPI has remained very similar. KAS: The First Six Months Table III.1b

Kidney recovery & utilization under KAS (cont) Kidney Discard Rate by KDPI -- including months 7-10 (Jun – Sep ‘15)  Discard rates have returned to pre-KAS levels in recent months. KAS: The First Six Months

Summary: First Six Months of KAS  Overall – KAS is meeting key goals  Highly successful 6-month pre-KAS preparation period  Decrease in longevity mismatches  Increase in the number of transplants among very highly sensitized patients  Increase in access to transplant for African Americans candidates  “Bolus effects”: the percent of transplants to CPRA % and dialysis>10 years recipients are both tapering post-KAS  Increase in A2/A2B  B transplants, but still room for growth  Transplant volume up 1% KAS: The First Six Months

Summary: First Six Months of KAS (cont’d)  Several trends deserve further attention:  Fewer 0MM transplants  Slight drop in pediatric transplants will continue to be tracked closely  Logistical challenges in allocation  Increased CIT and DGF  Increase in discard rates, particularly KDPI>85% kidneys. Rates appear to be returning back to pre-KAS levels based on months  Other metrics (e.g., graft survival rates) require additional lag time and will be available in future reports KAS: The First Six Months

26 Latest VCA Data

27 Approved VCA Transplant Programs* as of 10/23/2015 VCA TypeN Upper Limb 17 Head and Neck 13 Abdominal Wall 12 Other Specify: Uterine 3 Other Specify: Penile 2 Other Specify: Genitourinary 1 Other Specify: Lower Limb 1 Other Specify: Urogenital 1 Other Specify: Genitourinary (Excluding Lines) 1 Total* 51 * Represents 23 unique transplant centers

28 Geographic Locations of Approved VCA Transplant Centers as of 10/23/2015 Centers with at least one VCA registration currently waiting Centers with no VCA registrations currently waiting

29 VCA Waiting List and Transplant Numbers as of 10/23/2015 by Type

30 Other Organs Recovered from 8 VCA Donors, 7/3/ /23/2015 Non-VCA OrganN Heart6 Intestine2 Kidney13 Kidney-Pancreas1 Liver8 Lung4 Pancreas1 Total35 Demographics of VCA Donors, 7/3/ /23/2015 N% Age GenderMale EthnicityWhite675.0 Black112.5 Hispanic112.5

Redesigning Liver Distribution

32 Redesigning Liver Distribution (cont.) The Committee unanimously resolved to consider additional results in modeling of concepts previously developed and to further analyze an additional concept… Board Resolution Concept presented to Committee Statement to the Community Development of Steering Committee Concept Paper & Questionnaire September 2014 Liver Forum Development of the Ad Hoc Subcommittees Additional Modeling and Analyses June 2015 Forum Additional Modeling and Analyses

33 Metrics and quality improvement MPSC Outcomes workgroup OPO metrics Member Quality pilot Real life lessons

34 Acknowledgements  Darren Stewart  John Beck  Anna Kucheryavaya  Wida Cherikh  James Alcorn  Christine Flavin

35 OPTN Update Brian Shepard Chief Executive Officer UNOS November 17, 2015